Vol. 274, Issue 2, F243-F251, February 1998
Apical and basolateral uptake and intracellular fate of
dopamine precursor L-dopa in
LLC-PK1 cells
P.
Soares-Da-Silva,
M. P.
Serrão, and
M. A.
Vieira-Coelho
Faculty of Medicine, Institute of Pharmacology and Therapeutics,
4200 Porto, Portugal
 |
ABSTRACT |
The present study was aimed at the uptake of
L-3,4-dihydroxyphenylalanine
(L-dopa) and its intracellular
decarboxylation to dopamine. The accumulation of
L-dopa from the apical side in
cells cultured in collagen-treated plastic was found to be a saturable process with a Michaelis constant
(Km)
of 123 ± 17 µM and a maximal velocity
(Vmax) of 6.0 ± 0.2 nmol · mg
protein
1 · 6 min
1. The uptake of
L-dopa applied from either the
apical or basal cell borders in cells cultured in polycarbonate filters
was also found to be saturable; nonlinear analysis of saturation curves for apical and basal application revealed
Km values of 63.8 ± 17.0 and 42.5 ± 9.6 µM and
Vmax
values of 32.0 ± 5.8 and 26.2 ± 3.4 nmol · mg
protein
1 · 6 min
1, respectively. Cell
monolayers incubated with
L-dopa, applied from either the
apical or the basal side, in the absence of benserazide, led to the
accumulation of newly formed dopamine. The intracellular accumulation
of newly formed dopamine was a saturable process with apparent
Km values of
20.5 ± 8.2 and 247.3 ± 76.8 µM when the substrate
was applied from the apical and basal side, respectively. Some of the
newly formed dopamine escaped to the extracellular milieu. The basal
outward transfer of dopamine was five- to sevenfold of that occurring
at the apical side and was uniform over a wide range of concentrations
of intracellular dopamine; the apical outward transfer of the amine
depended on the intracellular concentration of dopamine and was a
nonsaturable process. The apical and basal outward transfers of
dopamine were insensitive to cocaine (10 and 30 µM) and GBR-12909 (1 and 3 µM). The accumulation of exogenous dopamine in
LLC-PK1 cells was found to be
saturable; nonlinear analysis of the saturation curves revealed for the
apical and basal application of dopamine a
Km of 17.7 ± 4.3 and 96.0 ± 28.1 µM and a
Vmax of 2.0 ± 0.1 and 2.2 ± 0.3 nmol · mg
protein
1 · 6 min
1, respectively.
However, both cocaine (10, 30, or 100 µM) and GBR-12909 (1 or 3 µM)
were found not to affect the uptake of 100 µM dopamine applied from
either the apical or the basal cell border. In conclusion, the data
presented here show that LLC-PK1
cells are endowed with considerable aromatic
L-amino acid decarboxylase (AADC) activity and transport
L-dopa quite efficiently through both the apical and basal cell borders. On the other hand, our observations support the possibility of a basal-to-apical gradient of
AADC activity and the possibility that
LLC-PK1 cells might constitute an
interesting in vitro model for the study of the renal dopaminergic
physiology.
L-3,4-dihydroxyphenylalanine; decarboxylase
 |
INTRODUCTION |
ENDOGENOUS DOPAMINE in the kidney has a role in
regulating sodium excretion through the activation of specific dopamine
receptors located in tubular epithelial cells (1-3, 7, 23). The
current view of the renal dopaminergic system is that of a local
nonneuronal system constituted by epithelial cells of proximal
convoluted renal tubules rich in aromatic
L-amino acid decarboxylase
(AADC) activity and using circulating or filtered
L-3,4-dihydroxyphenylalanine (L-dopa) as a source for
dopamine (18, 19, 29). Because the dopamine produced in this area is in
close proximity to renal cells that contain receptors for the amine, it
has been hypothesized that the amine may act as a paracrine or
autocrine substance (25). The relative importance of this system in
controlling natriuresis assumes particular relevance in view of the
findings that salt-sensitive hypertensive subjects have a fault in
renal dopamine production and this may be associated with salt
sensitivity of their blood pressure (19). Urinary
L-dopa has been found to be
greater in salt-sensitive than in salt-resistant hypertensive and
normotensive subjects during low- or high-sodium intake. The mean ratio
of dopamine to L-dopa has also
been found to be subnormal during low- and high-sodium intake,
suggesting that salt-sensitive hypertensives might have a reduced
capacity to synthesize dopamine (8, 9, 17).
A deficient production of renal dopamine might arise from a reduced
delivery of the substrate to the kidney, a reduced uptake of
L-dopa into tubular epithelial
cells, or a reduced rate of conversion of
L-dopa into dopamine. Although
the kidney is endowed with one of the highest levels of AADC in the
body, the enzyme responsible for the conversion of
L-dopa to dopamine, and the plasma levels of L-dopa are in
the range of nanomoles per milliliter (12, 37), it is not known which
is the rate-limiting step for the synthesis of dopamine in renal
tissues. Early studies have demonstrated that the renal tubular
transport of L-dopa occurs through an energy-dependent and stereoselective carrier-mediated process (5). More recently, the synthesis of dopamine in tubular epithelial cells has been shown to be closely dependent on
extracellular sodium, the mechanisms involved in transtubular
reabsorption of sodium (33, 34, 36), and the integrity of the tubular
cytoskeleton and the functional integrity of sodium potassium
adenosinetriphosphatase (26). The rise of intracellular levels of
guanosine 3',5'-cyclic monophosphate (cGMP), as induced by
the
-human atrial natriuretic peptide, by zaprinast
(May & Baker 22,948), a relatively specific cGMP phosphodiesterase
inhibitor, or by 8-bromo-cGMP, has also been found to restrict the
intracellular availability of
L-dopa and decrease the renal
formation of dopamine (30, 31). However, despite the evidence of an
association among the tubular reabsorption of sodium, the levels of
cGMP, and the uptake of L-dopa,
information is still lacking on the nature and the characteristics of
the rate-limiting step for the renal formation of dopamine. On the other hand, maneuvers that modify the urinary excretion of dopamine have been demonstrated in parallel with changes with renal AADC activity (14, 22, 27, 32).
The present study was aimed at addressing the question concerning which
of the processes, the cellular uptake of
L-dopa or its intracellular
decarboxylation by AADC, is rate limiting to the formation of dopamine.
To obviate technical problems related to the handling of freshly
isolated renal tubular epithelial cells, this study was performed in
monolayers of LLC-PK1 cells in
culture. LLC-PK1 cells express
proximal tubule cell-like properties in vitro (16) and have been used
for the purpose of studying dopamine receptors and the renal actions of
the amine. These cells also have been shown to contain high levels of
AADC and to convert L-dopa to
dopamine in a nonsaturable fashion for up to 1 mM
L-dopa (6, 10, 11). Newly formed
dopamine also stimulated adenosine 3',5'-cyclic
monophosphate accumulation in
LLC-PK1 cells, and this effect was
attenuated by an equimolar concentration of carbidopa and blocked by
the D1 antagonist Sch-23390 (11). It appears, therefore,
that in LLC-PK1 cells, as in
epithelial cells of proximal tubules, locally formed dopamine can act
as an autocrine/paracrine substance. We report here that
LLC-PK1 cells take up
L-dopa through a saturable,
stereoselective, and temperature-dependent process when it is applied
from the apical and basolateral cell border, but the rate-limiting step
for the formation of dopamine in these renal epithelial cells depends
on the intracellular decarboxylation of
L-dopa.
 |
METHODS |
Cell culture.
LLC-PK1, a porcine-derived
proximal renal tubule epithelial cell line that retains several
properties of proximal tubular epithelial cells in culture (16), was
obtained from the American Type Culture Collection (ATCC, Rockville,
MD) and maintained in a humidified atmosphere of 5%
CO2-95% air at 37°C.
LLC-PK1 cells (ATCC CRL 1392;
passages 198-206) were grown in medium 199 (Sigma Chemical, St.
Louis, MO) supplemented with 100 U/ml penicillin G, 0.25 µg/ml
amphotericin B, 100 µg/ml streptomycin (Sigma), 3% fetal bovine
serum (Sigma), and 25 mM
N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (Sigma). For subculturing, the cells were dissociated with 0.05%
trypsin-EDTA, split 1:4, and subcultured in Costar flasks with 75- or
162-cm2 growth areas (Costar,
Badhoevedorp, The Netherlands). For uptake studies, the cells were
seeded in collagen-treated 24-well plastic culture clusters (16 mm ID,
Costar) at a density of 40,000 cells/well (2.0 × 104
cells/cm2) or, depending on the
experiment, onto collagen-treated 0.2-µm polycarbonate filter
supports (12 mm ID, Transwell; Costar). The cell medium was changed
every 2 days, and the cells reached confluence after 3-5 days of
incubation. For 24 h before each experiment, the cell medium was free
of fetal bovine serum. Experiments were generally performed 2-3
days after cells reached confluency and 6-8 days after the initial
seeding and each square centimeter contained ~130 µg of cell
protein.
Transport studies.
On the day of the experiment, the growth medium was aspirated and the
cells were washed with Hanks' medium at 4°C; thereafter, the cell
monolayers were preincubated for 15 min in Hanks' medium at 37°C.
Hanks' medium had the following composition (in mM): 137 NaCl, 5 KCl,
0.8 MgSO4, 0.33 Na2HPO4,
0.44 KH2PO4,
0.25 CaCl2, 1.0 MgCl2, 0.15 tris(hydroxymethyl)aminomethane hydrochloride, and 1.0 sodium butyrate,
pH 7.4. The incubation medium also contained pargyline (100 µM) and
tolcapone (1 µM) to inhibit the enzymes monoamine
oxidase and catechol
O-methyltransferase, respectively; in
some experiments, benserazide (50 µM) was also added to the incubation medium to inhibit AADC. During preincubation and incubation, the cells were continuously shaken and maintained at 37°C.
In the first series of experiments, uptake studies were performed in
cells cultured in collagen-treated plastic supports, with the
substrates being applied from the apical cell border only. Uptake was
initiated by the addition of 2 ml Hanks' medium with a given
concentration of the substrate under study. Determination of initial
rate of uptake was performed in experiments in which cells were
incubated with a nonsaturating concentration of
L-dopa during 1, 3, 6, 12, 30, 60, and 120 min. Saturation experiments were performed in
LLC-PK1 cells incubated for 6 min
with increasing concentrations of the substrates; some experiments were
conducted at 4°C. Uptake was terminated by the rapid removal of
uptake solution by means of a vacuum pump connected to a Pasteur
pipette, followed by two rapid washes with cold Hanks' medium and the
addition of 250 µl of 0.2 mM perchloric acid; the acidified samples
were stored at 4°C before injection into the high-pressure liquid
chromatograph for the assay of
L-dopa,
D-dopa, benserazide, and
dopamine.
In another series of experiments, cells were cultured in polycarbonate
supports, with the substrates being applied from the apical or the
basal side of the monolayer. The incubation medium used in this series
of experiments was similar to that described above; in some
experiments, the medium contained benserazide (50 µM) to inhibit
AADC. The upper and lower chambers contained 600 µl and 200 µl,
respectively. For apical uptake, the uptake solution was added to the
upper chamber, whereas for basolateral uptake, the uptake solution was
added to the lower chamber. Cells were preincubated for 15 min and
thereafter incubated for 6 min in the presence of
L-dopa. At the end of
incubation, cells were placed on ice, and the medium bathing the apical
and basal cell borders was collected, acidified with perchloric acid,
and stored at 4°C until assay for
L-dopa and dopamine. The cells
were washed with ice-cold Hanks' medium and combined with 0.2 mM
perchloric acid (100 and 500 µl in the upper and lower chambers,
respectively); the acidified samples were stored at 4°C before
injection into the high-pressure liquid chromatograph for the assay of
L-dopa and dopamine.
The last series of experiments was also performed in cells cultured in
polycarbonate filters and was aimed at testing the effects of cocaine
and GBR-12909 on the apical and basal outflow of newly formed dopamine
and apical and basal uptake of exogenous dopamine. Cells were
preincubated for 30 min in the presence of cocaine (10, 30, and 100 µM) or GBR-12909 (1 and 3 µM), and
L-dopa (250 µM) or dopamine
(100 µM) was then applied from the apical or the basal side of the
cell monolayer. At the end of incubation, cells were placed on ice, and
the medium bathing the apical and basal cell borders was collected,
acidified with perchloric acid, and stored at 4°C until assay for
L-dopa and dopamine; cells were handled as mentioned above for determination of intracellular L-dopa and dopamine.
AADC preparation and decarboxylation
studies.
LLC-PK1 cells were homogenized in
0.5 M phosphate buffer (pH 7.0) with a Thomas Teflon homogenizer and
kept continuously on ice. Aliquots of 250 µl cell homogenate plus 250 µl incubation medium were placed in glass test tubes and preincubated
for 15 min. Thereafter, L-dopa
(50-10,000 µM) was added to the medium for an additional 15 min;
the final reaction volume was 1 ml. The composition of the incubation
medium was as follows (in mM): 0.35 NaH2PO4,
0.15 Na2HPO4,
0.11 sodium borate, and 0.12 pyridoxal phosphate; tolcapone (1 µM)
and pargyline (100 µM) were also added to the medium. The pH of the
reaction medium was kept constant at an optimal pH 7.0 (24). During
incubation, cell homogenates were continuously shaken and gassed (95%
O2-5%
CO2) and maintained at 37°C.
The reaction was stopped by the addition of 500 µl of 2 M perchloric
acid, and the preparations were kept at 4°C for 60 min. The samples
were then centrifuged (200 g, 2 min, 4°C), and 500-µl
aliquots of the supernatant filtered on Spin-X filter tubes (Costar)
were used for the assay of dopamine.
Assay of L-dopa,
D-dopa, benserazide, and dopamine.
L-Dopa,
D-dopa, benserazide, and
dopamine were quantified by means of high-pressure liquid
chromatography with electrochemical detection, as previously reported
(35). The high-pressure liquid chromatograph system consisted of a pump
(model 302; Gilson Medical Electronics, Villiers le Bel, France)
connected to a manometric module (Gilson model 802C) and a stainless
steel 5-µm ODS column (Biophase; Bioanalytical Systems, West
Lafayette, IN) 25 cm in length; samples were injected by means of an
automatic sample injector (Gilson model 231) connected to a Gilson
dilutor (model 401). The mobile phase was a degassed solution of citric
acid (0.1 mM), sodium octylsulfate (0.5 mM), sodium acetate (0.1 M), EDTA (0.17 mM), dibutylamine (1 mM), and methanol (8% vol/vol), adjusted to pH 3.5 with perchloric acid (2 M) and pumped at a rate of
1.0 ml/min. The detection was carried out electrochemically with a
glassy carbon electrode, an Ag/AgCl reference electrode, and an
amperometric detector (Gilson model 141); the detector cell was
operated at 0.75 V. The current produced was monitored, using the
Gilson 712 HPLC software. The lower limits for detection of
L-dopa,
D-dopa, and dopamine ranged from
350 to 500 fmol.
Cell water content.
Cell water content was simultaneously measured in parallel experiments,
using [14C]inulin as
extracellular marker and tritiated water as total water marker.
Intracellular water obtained by subtracting extracellular water from
total water was expressed as microliters of cell water per milligram
protein. Subsequently, the cells were solubilized by 0.1% vol/vol
Triton X-100 (dissolved in 5 mM HCl, pH 7.4) and radioactivity was
measured by liquid scintillation counting.
Protein assay.
The protein content of monolayers of
LLC-PK1 cells was determined by
the method of Bradford (4), with human serum albumin as a standard.
Cell viability.
LLC-PK1 cells were preincubated
for 15 min at 37°C and then incubated in the absence or presence of
L-dopa,
D-dopa, and dopamine for an
additional 15 or 120 min. Subsequently, the cells were incubated at
37°C for 2 min with trypan blue (0.2% wt/vol) in phosphate buffer.
Incubation was stopped by rinsing the cells twice with Hanks' medium,
and the cells were examined with the use of a Leica microscope. Under
these conditions, >95% of the cells excluded the dye.
Data analysis.
The analysis of the time course of
L-dopa uptake in
LLC-PK1 cells was based on a
one-compartment model. The parameters of the
equation
were
fitted to the experimental data by a nonlinear regression analysis,
using a computed assisted method (20).
Ci and Co represent the intracellular and
extracellular concentration of the substrate, respectively;
kin is the rate
constant for inward transport,
kout is the rate
constant for outward transport, and t
is the incubation time. Values of
kin and
kout are given in picomoles per milligram protein per minute.
Amax is defined as the factor of
accumulation
(Ci/Co)
at equilibrium (t
).
Michaelis constant
(Km) and
maximal velocity
(Vmax) values
for the uptake of substrates, as determined in saturation experiments,
and decarboxylation of L-dopa in
cell homogenates were calculated from nonlinear regression analysis,
using the GraphPad Prism statistics software package (20). The linear
rate of accumulation (RA) or outward transfer (RT) was determined by
the slope of the accumulation of substrates measured by linear
regression analysis (21). Arithmetic means ± SE are given.
Statistical analysis was performed by one-way analysis of variance
followed by Newman-Keuls test for multiple comparisons. A value of
P < 0.05 was assumed to denote a
significant difference.
Drugs.
Drugs used were L-dopa (Sigma),
dopamine hydrochloride (Sigma), GBR-12909 (Research Biochemicals
International, Natick, MA), pargyline hydrochloride (Sigma), and
tolcapone (kindly donated by the late Prof. Mosé Da Prada,
Hoffmann La Roche, Basel, Switzerland).
 |
RESULTS |
To determine total
kin and
kout,
LLC-PK1 cells were incubated with
L-dopa (0.5 µM) for 1, 3, 6, 12, 30, 60, and 120 min in the presence of benserazide
(Fig. 1).
L-Dopa was rapidly accumulated in LLC-PK1 cells; equilibrium was
attained at 30 min of incubation. From the initial rate of uptake,
kin,
kout, and
Amax were calculated. The analysis
revealed a kin of
3.6 ± 0.4 pmol · mg
protein
1 · min
1,
a kout of 1.0 ± 0.1 pmol · mg
protein
1 · min
1,
and an Amax of 15.9 ± 0.9 (n = 8). In other words, an amount of
LLC-PK1 cells corresponding to 1 mg of protein cleared ~7 µl incubation medium of
L-dopa per minute, and,
simultaneously, 13% of intracellular
L-dopa left the cells. The
intracellular water content of cell monolayers was 7.1 ± 0.6 µl/mg protein (n = 12). At
equilibrium (30 min incubation), the intracellular
L-dopa concentration was 7.9 ± 0.5 µM at medium concentration of 0.5 µM. This represented a
cell concentration of L-dopa
that was 16 times higher than the medium concentration.

View larger version (11K):
[in this window]
[in a new window]
|
Fig. 1.
Time course of
L-3,4-dihydroxyphenylalanine
(L-dopa) accumulation in
LLC-PK1 cells. Cells were
incubated at 37°C with 0.5 µM
L-dopa. Cells were cultured in
collagen-treated plastic, and substrate was applied from apical side
only. Exponential saturation curves were fitted to experimental data.
Symbols and vertical lines represent means ± SE, respectively, of 5 experiments/group.
|
|
In time-course experiments, the accumulation for
L-dopa increased linearly with
time for several minutes (Fig. 1). Thus, in all subsequent experiments
designed to determine the kinetic parameters for the uptake of
L-dopa and other substrates, the
cells were incubated for 6 min with increasing concentrations
(0.5-500 µM) of compounds of interest. The accumulation of
L-dopa from the apical cell
border was found to be dependent on the concentration used and to be
saturable at 250 µM (Fig.
2A).
Nonlinear analysis of the saturation curves revealed a
Km of 123 ± 17 µM and a
Vmax of 6.0 ± 0.2 nmol · mg
protein
1 · 6 min
1. In experiments
carried out at 4°C, the amount of
L-dopa accumulated in the cells
was markedly lower than that observed at 37°C and was found to be
nonsaturable (Fig. 2A).
LLC-PK1 cells incubated at
37°C with increasing concentrations of
D-dopa instead of
L-dopa were found to accumulate
trace amounts of the D-isomer;
the cellular accumulation of
D-dopa at the highest
concentration used was ~5% of the corresponding
L-isomer (Fig.
2A). Results shown in Figs. 1 and
2A were from experiments performed in
the presence of benserazide (50 µM), to avoid the intracellular
decarboxylation of L-dopa taken
up by AADC. Benserazide is an effective AADC inhibitor, and 50 µM
benserazide has been found to completely abolish the decarboxylation of
L-dopa. However, it is not known
whether benserazide may also interfere with the cellular uptake of
L-dopa, given the structural
similarities between these two compounds. It is, however, almost
impossible to test L-dopa uptake
in a cell system endowed with AADC activity. Therefore, the apical
uptake of benserazide was studied to determine whether the accumulation
of the AADC inhibitor in these cells proceeded differently from that of
L-dopa. Incubation of
LLC-PK1 cells with increasing
concentrations of benserazide also resulted in a nonsaturable
accumulation of the compound (Fig.
2B); at 500 µM, the amount of
benserazide accumulated in the cells was only 5% of the amount of
L-dopa accumulated under similar
conditions. This suggests that benserazide enters the cells through a
process completely different from that used by L-dopa, although it does not
prove that benserazide is devoid of effects on the uptake process of
L-dopa.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 2.
A: rate of accumulation of
L-dopa (squares) and
D-dopa (circles) in
LLC-PK1 cells incubated for 6 min
at 37°C (solid symbols) or 4°C (open symbols); linear
coefficient values: L-dopa
4°C, r2 = 0.985065, n = 24;
D-dopa 37°C,
r2 = 0.999359, n = 24;
D-dopa 4°C,
r2 = 0.979165, n = 24. B: rate of accumulation of benserazide
in LLC-PK1 cells incubated for 6 min at 37°C (solid symbols) or 4°C (open symbols); linear
coefficient values: 37°C,
r2 = 0.994105, n = 24; 4°C,
r2 = 0.974557, n = 24. A and
B: cells were cultured in
collagen-treated plastic, and increasing concentrations (0.5-500
µM) of substrates were applied from apical border. Symbols and
vertical lines represent means ± SE, respectively, of 4-5
experiments/group.
|
|
The next series of experiments was performed in cells cultured in
polycarbonate filters, and
L-dopa was applied from either the apical or the basal border; intracellular
L-dopa and
L-dopa that escaped to the fluid
bathing the basal or the apical cell borders were also measured. The
uptake of L-dopa applied from either the apical or basal cell borders was dependent on the
concentration and was found to be saturable (Fig.
3); nonlinear analysis of saturation curves
for apical and basal application revealed
Km values of 63.8 ± 17.0 and 42.5 ± 9.6 µM and
Vmax values of
32.0 ± 5.8 and 26.2 ± 3.4 nmol · mg
protein
1 · 6 min
1, respectively.

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 3.
Rate of accumulation of L-dopa
in LLC-PK1 cells cultured in
polycarbonate filters and incubated for 6 min at 37°C; substrate
was applied from either apical ( ) or basal ( ) cell border.
Symbols and vertical lines represent means ± SE, respectively, of
4-5 experiments/group.
|
|
Incubation of homogenates of
LLC-PK1 cells with
L-dopa (50-10,000 µM)
resulted in a concentration-dependent formation of dopamine (Fig.
4). The decarboxylation process was found
to be linear up to 1 mM L-dopa
and to become saturated at high concentrations of the substrate
(2.5-10 mM L-dopa).
Nonlinear analysis of the saturation curves revealed a
Km of 1,866 ± 107 µM and a
Vmax of 4.4 ± 0.1 nmol · mg
protein
1 · 15 min
1.

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 4.
Saturation curve of aromatic
L-amino acid decarboxylase
(AADC) activity in homogenate
LLC-PK1 cells. AADC activity is
expressed as rate of formation of dopamine (DA; in
nmol · mg
protein 1 · 15 min 1) vs. concentration
of L-dopa (µM). Symbols
represent means ± SE of 5 experiments/group.
|
|
Because LLC-PK1 cells were found
to be endowed with considerable AADC activity, the cell monolayers were
incubated with L-dopa, applied
from either the apical or the basal side, in the absence of
benserazide, and the intracellular concentrations of newly formed
dopamine and the amount of dopamine that had escaped to the fluid
bathing the apical and the basal cell borders were determined. Cells
were incubated with increasing concentrations of
L-dopa (5-500 µM) for 6 min. Figure 5 shows the intracellular
levels of newly formed dopamine when
L-dopa was applied from either
the apical or the basal cell border. It is interesting to note that the
intracellular accumulation of newly formed dopamine was a rapidly
saturable process with an apparent
Km value of 20.5 ± 8.2 µM when the substrate was applied from the apical side. By contrast, when the substrate was applied from the basal side, the
accumulation of newly formed dopamine in the intracellular compartment
was less readily saturable (apparent
Km of 247.3 ± 76.8 µM). However, intracellular levels of newly formed dopamine attained at 500 µM L-dopa
were, under both experimental conditions (apical or basal application
of L-dopa), of about the same
magnitude. Table 1 shows the percentage of
intracellular L-dopa that was decarboxylated to dopamine when the substrate was applied from either
the apical or the basal side. As can be observed, the percentage of
intracellular L-dopa that
undergoes decarboxylation to dopamine decreases progressively with the
increase in extracellular
L-dopa. Conversely, the
decarboxylation of L-dopa
applied from the basal side was found to be greater
(P < 0.05) than that occurring when L-dopa was applied from the
apical side (Table 1); this was particularly evident from 5 to 100 µM
of L-dopa.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 5.
Rate of formation of dopamine in
LLC-PK1 cells loaded with
increasing concentrations of
L-dopa. Cells were preincubated
in absence of benserazide for 30 min and incubated for 6 min with
increasing concentrations of
L-dopa; substrate was applied
from either apical ( ) or basal ( ) cell border. Symbols and
vertical lines represent means ± SE, respectively, of 4-5
experiments/group.
|
|
Some of the newly formed dopamine was found to escape from the
intracellular compartment to the extracellular milieu; this occurred
when L-dopa was applied from
either the apical or the basal cell side (Fig.
6). The levels of dopamine in the medium bathing the basal cell side were, under both experimental conditions (apical or basal application of
L-dopa), considerably greater (5- to 7-fold) than those observed in the medium bathing the apical cell border (Fig. 6). Another interesting difference concerning the
basal outward transfer of newly formed dopamine is that apparently it
did not depend on the intracellular concentration of the amine (Fig.
6B), whereas the apical outward
transfer of dopamine was dependent on the intracellular concentration
of dopamine (Fig. 6A). The RT
of dopamine, as determined by linear regression analysis, was 0.365 ± 0.042 mmol
1
(r2 = 0.950;
n = 24) and 0.425 ± 0.061 mmol
1
(r2 = 0.923;
n = 24) for the apical and basal
application of L-dopa, respectively.

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 6.
Reciprocal plot of intracellular dopamine (DA; in mmol/l) that has been
formed in LLC-PK1 cells loaded
with increasing concentrations of
L-dopa (10-500 µM) and
amount of dopamine that escaped to incubation medium (in pmol/mg
protein) bathing apical (A) and
basal (B) cell borders. Cells were
preincubated in absence of benserazide for 30 min and incubated for 6 min with increasing concentrations of
L-dopa; substrate was applied
from either apical ( ) or basal ( ) cell border. Symbols and
vertical lines represent means ± SE, respectively, of 5 experiments/group. Linear coefficient values: apical to basal,
r2 = 0.9498, n = 30; basal to apical,
r2 = 0.9228, n = 30. All values for dopamine in
medium bathing basal side were significantly different
(P < 0.05) from corresponding
dopamine levels in fluid bathing apical side (Newman-Keuls test).
|
|
To define whether the apical and basal outward transfer of newly formed
dopamine was mediated through a monoamine transporter, the influence of
cocaine (10 and 30 µM) and GBR-12909 (1 and 3 µM) was determined.
Cells were loaded with L-dopa
(250 µM) applied from the basal side, and the levels of intracellular
dopamine and the levels of the amine in the fluid bathing the apical
and basal sides were determined. As can be observed in Table
2, both cocaine and GBR-12909 were found
not to affect the intracellular levels of newly formed dopamine and the
apical or basal outward transfer of the amine.
View this table:
[in this window]
[in a new window]
|
Table 2.
Levels of newly formed dopamine in intracellular compartment (cell) and
in medium bathing apical and basal sides and effect of cocaine and
GBR-12909
|
|
In the final series of experiments, we addressed the question of the
type of inward movement of dopamine in
LLC-PK1 cells. Exogenous dopamine
(5-250 µM) was applied from the apical or the basal side for 6 min. The accumulation of exogenous dopamine in LLC-PK1 cells was found to be
saturable (Fig. 7); nonlinear analysis of
the saturation curves revealed for the apical and basal application of
dopamine a Km of
17.7 ± 4.3 and 96.0 ± 28.1 µM and a
Vmax of 2.0 ± 0.1 and 2.2 ± 0.3 nmol · mg
protein
1 · 6 min
1, respectively.
However, both cocaine (10, 30, or 100 µM) and GBR-12909 (1 or 3 µM)
were found not to affect the uptake of 100 µM dopamine applied from
either the apical or the basal cell border (Fig.
8).

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 7.
Rate of accumulation of exogenous dopamine (DA) in
LLC-PK1 cells cultured in
polycarbonate filters and incubated for 6 min at 37°C; substrate
was applied from either apical ( ) or basal ( ) cell border.
Symbols and vertical lines represent means ± SE, respectively, of
4-5 experiments/group.
|
|

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 8.
Effect of GBR-12909 (cross-hatched bars) and cocaine (open bars) on
uptake of exogenous dopamine (100 µM) in
LLC-PK1 cells cultured in
polycarbonate filters and incubated for 6 min at 37°C; substrate
was applied from either apical (A)
or basal (B) cell border. Absolute
values under control conditions (solid bars) for apical and basal
application were 0.76 ± 0.06 and 2.47 ± 0.67 nmol/mg protein,
respectively. Bars represent means of 4 experiments/group and vertical
lines show SE.
|
|
 |
DISCUSSION |
The results presented here show that
LLC-PK1 cells transport
L-dopa quite efficiently through
both the apical and basolateral cell borders. Intracellular
L-dopa is rapidly converted to
dopamine, but the synthesis of the amine in
LLC-PK1 cells becomes a
rate-limiting step when high concentrations of
L-dopa are used. Intracellular newly formed dopamine leaves the cell through the apical border by a
diffusional process, whereas dopamine leaving the cell through the
basal cell border appears to be transported readily by a saturable process. Both processes are, however, insensitive to inhibitors of the
dopamine transporter, cocaine and GBR-12909. The apical and basal
uptake of extracellular dopamine behaves as a saturable process with
low affinity for the substrate; this is also insensitive to cocaine and
GBR-12909. With consideration of the information provided here on the
cell handling of L-dopa and
newly formed dopamine and previous evidence on the autocrine/paracrine
effects of newly formed dopamine mediated through specific dopamine
receptors, it is suggested that these cells constitute a useful in
vitro model for the study of the renal dopaminergic physiology.
Several findings demonstrate that the apical uptake of
L-dopa into
LLC-PK1 cells was a facilitated
mechanism. First, steady-state uptake of nonsaturating concentrations
of L-dopa showed a curvilinear dependence on incubation time. Second, at the initial rate of uptake (6 min incubation), the cellular transport of
L-dopa showed a curvilinear
dependence on L-dopa medium
concentration with a Km of 123 µM,
suggesting that the uptake was saturable. Third, this accumulation of
L-dopa was nearly abolished at
4°C, demonstrating that the uptake was energy dependent. The
efficiency of the L-dopa transport in LLC-PK1 cells also
can be evidenced by the ratio of
L-dopa concentration in cellular
water to medium concentration. It was found that intracellular
L-dopa concentration at
equilibrium was larger than that which could be expected by passive
equilibration of L-dopa. In
fact, at steady-state uptake, the mean intracellular concentration of
L-dopa was 16 times larger than
L-dopa concentration in the
incubation medium. Finally, the finding that
D-dopa transport was
nonsaturable indicates that the uptake of
L-dopa is stereoselective. This
agrees with previous evidence on the uptake of
L-dopa obtained in isolated rat
renal proximal tubules. Chan (5) has shown that the uptake of
L-dopa in perfused rat renal
tubules is energy dependent and stereoselective; similar findings have
been also observed in more recent investigations, using suspensions of
isolated rat renal tubules loaded with
L-dopa (28, 35). Experiments carried out in cells cultured in polycarbonate filters showed that the
apical uptake of L-dopa is
similar to that observed when the substrate is applied from the basal
cell border. It is interesting, however, to observe that the apical
uptake of L-dopa in cells cultured in polycarbonate filters differs substantially from that observed in cells cultured in collagen-treated plastic, with the main
differences being a lower
Km value (32 ± 4 vs. 123 ± 17 µM) and a higher
Vmax value (32.0 ± 4.4 vs. 5.8 ± 0.2 nmol · mg
protein
1 · 6 min
1). A possible
explanation for this discrepancy may have to do with the different
environment of cells cultured in a more physiological system, such as
in polycarbonate filters.
The role of the L-dopa
transporter in the whole process of dopamine formation is still an open
question, i.e., the rate-limiting step in the formation of the amine
has not been clearly identified. To defined which of the processes, the
uptake process or the decarboxylation process, rate limits the
formation of dopamine, LLC-PK1
cells were incubated in the absence of benserazide, and the
intracellular levels of L-dopa
and dopamine were determined. As shown in Fig. 5 and Table 1, the
process of dopamine formation is rapidly saturable, and a substantial
amount of L-dopa taken up is
converted to dopamine. This is particularly evident for low
concentrations of the substrate (5-50 µM), which most probably
are still above the range of physiological levels of
L-dopa in renal tissues; plasma
levels range between 5 and 10 pmol/ml (37). There are, however, marked
differences in this process of intracellular decarboxylation of
L-dopa, depending on
whether the substrate is applied from the apical or the basal cell
border. In fact, saturation of intracellular decarboxylation of
L-dopa is readily attained when
the substrate is applied from the apical cell border
(Km = 20.5 ± 8.2 µM), which contrasts with that observed when the substrate is
applied from the basal cell border
(Km = 247.3 ± 76.8 µM). This marked difference may suggest the presence at the
basolateral cell pole of an intracellular storage compartment devoid of
AADC activity, which prevents intracellular L-dopa from being converted to
dopamine. The capacity of these hypothetical
L-dopa storage compartments
appears, however, to be quite limited, since at 500 µM
L-dopa, in the extracellular medium, the formation of dopamine attains the same
Vmax value as
when the substrate is applied from the apical cell border. Alternatively, it might suggest a heterogeneous distribution of AADC in the cell, with the predominant pool being
concentrated near the apical pole of the cell. This is
the most likely explanation and would agree with the evidence
obtained in histofluorescence studies showing that
L-dopa-induced fluorescence
prevails at the apical pole of epithelial cells of rat renal proximal
tubules (13).
The intracellular fate of newly formed dopamine is another interesting
point to discuss. The present study has also evaluated the outward
transfer of newly formed dopamine through the apical and basal cell
borders, and the data obtained clearly show that the former transfer is
a diffusional process, whereas the latter may be an easily saturable
one. The finding that the outward movement of intracellular dopamine
through the apical cell border is nonsaturable within a range of
intracellular concentrations of dopamine from 0.3 to 1.4 mM strongly
suggests that this a diffusional process; this can be observed when
L-dopa is applied from either
the apical or the basal cell border. This contrasts with that observed
at the basal cell border; the outward movement of newly formed dopamine was quite stable over a wide range of intracellular concentration of
the amine. This may suggest that the outward transfer of dopamine is a
high-affinity, readily saturable process. The experiments carried out
in the presence of cocaine and GBR-12909, two potent inhibitors of the
dopamine transporter (15), showed that this transfer of dopamine is not
sensitive to these inhibitors, suggesting that the hypothetical
dopamine transfer process does not have the pharmacological profile of
the classic dopamine transporter. The alternative explanation that the
basal cell pole is endowed with a higher ability to take up the
"released" dopamine is not compatible with the finding that
Km values for
uptake of exogenous dopamine applied from the basal cell side are
higher than those observed for the apical cell border. It is, however,
quite clear that the basal cell border is much leakier than the apical
cell border, considering the outward movement of dopamine. Because the
volumes of incubation medium bathing the apical and basal sides
differed by a factor of three (200 vs. 600 µl), it could be
hypothesized that the higher ability of dopamine to leave the cellular
compartment was due to differences in extracellular
water-to-intracellular water ratios. In consideration of the fact that
intracellular water in cells grown in permeable supports attains a
volume of 0.23 µl (7 µl/mg protein:33 µg cell
protein), these ratios would be 870 and 2,600 for the apical and basal
cell sides, respectively. The highest intracellular concentration of
dopamine was 1.36 ± 0.06 mmol/l; the corresponding concentrations
of dopamine in the medium bathing the apical and basal cell sides were
0.04 ± 0.02 and 0.39 ± 0.05 mmol/l, respectively.
This clearly suggests that the 870-fold difference between
extracellular and intracellular water is enough to allow a gradient to
be established.
It is, however, worthwhile to underline the finding that the inward
transfer of exogenous dopamine is, in contrast to that found to occur
for the outward transfer of the newly formed dopamine, a saturable
process when applied from either the apical or the basal cell border.
However, the kinetic profile of the uptake process found to occur at
the apical cell border presented a higher affinity for the substrate,
as evidenced by a fivefold lower
Km value. The
affinity of this transporter for exogenous dopamine was, however, lower
than that described for the dopamine transporter sensitive to cocaine
or GBR-12909. This agrees with the finding that both cocaine (10, 30, and 100 µM) and GBR-12909 (1 and 3 µM) were ineffective in reducing
the uptake of dopamine applied either from the apical or the basal cell
border. These findings contrast with those obtained in OK cells, renal
cells derived from renal tubules of a female American opossum, in which
dopamine was demonstrated to be taken up by a saturable transporter
when applied from the basal cell border only. The data presented here on the uptake of dopamine by the apical cell border also contrast with
the finding that the renal transport of exogenous dopamine is
unidirectional from the basolateral to the apical cell border (5). This
should be taken into consideration when assuming LLC-PK1 cells as an in vitro model
for the study of renal tubular physiology.
In conclusion, the data presented here show that
LLC-PK1 cells are endowed with
considerable AADC activity and transport
L-dopa quite efficiently through
both the apical and basal cell borders. Intracellular
L-dopa is rapidly converted to
dopamine, and the rate of conversion of
L-dopa to dopamine does not
appear to rate limit the synthesis of the amine. On the other hand, our
observations support the possibility of a basal-to-apical gradient of
AADC activity and the possibility that
LLC-PK1 cells might constitute an
interesting in vitro model for the study of renal dopaminergic physiology.
 |
ACKNOWLEDGEMENTS |
This work was supported by Grant PRAXIS/2/2.1./SAU/1836/95 from
PRAXIS XXI.
 |
FOOTNOTES |
Address reprint requests to P. Soares-da-Silva.
Received 7 August 1996; accepted in final form 16 September 1997.
 |
REFERENCES |
1.
Aperia, A.,
A. Bertorello,
and
I. Seri.
Dopamine causes inhibition of Na+-K+-ATPase activity in rat proximal convoluted tubule segments.
Am. J. Physiol.
252 (Renal Fluid Electrolyte Physiol. 21):
F39-F45,
1987[Abstract/Free Full Text].
2.
Bertorello, A.,
and
A. Aperia.
Both DA1 and DA2 receptor agonists are necessary to inhibit NaKATPase activity in proximal tubules from rat kidney.
Acta Physiol. Scand.
132:
441-443,
1988[Medline].
3.
Bertorello, A.,
T. Hokfelt,
M. Goldstein,
and
A. Aperia.
Proximal tubule Na+-K+-ATPase activity is inhibited during high-salt diet: evidence for DA-mediated effect.
Am. J. Physiol.
254 (Renal Fluid Electrolyte Physiol. 23):
F795-F801,
1988[Abstract/Free Full Text].
4.
Bradford, M. M.
A rapid method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.
Anal. Biochem.
72:
248-254,
1976[Medline].
5.
Chan, Y. L.
Cellular mechanisms of renal tubular transport of L-DOPA and its derivatives in the rat: microperfusions studies.
J. Pharmacol. Exp. Ther.
199:
17-24,
1976[Abstract/Free Full Text].
6.
Dawson, R., Jr.,
and
M. I. Phillips.
Dopamine synthesis and release in LLC-PK1 cells.
Eur. J. Pharmacol.
189:
423-426,
1990[Medline].
7.
Felder, C. C.,
T. Campbell,
F. Albrecht,
and
P. A. Jose.
Dopamine inhibits Na+-H+ exchanger activity in renal BBMV by stimulation of adenylate cyclase.
Am. J. Physiol.
259 (Renal Fluid Electrolyte Physiol. 28):
F297-F303,
1990[Abstract/Free Full Text].
8.
Gill, J., Jr.,
E. Grossman,
and
D. S. Goldstein.
High urinary dopa and low urinary dopamine-to-dopa ratio in salt-sensitive hypertension.
Hypertension
18:
614-621,
1991[Abstract/Free Full Text].
9.
Gill, J., Jr.,
G. Gullner,
C. R. Lake,
D. J. Lakatua,
and
G. Lan.
Plasma and urinary catecholamines in salt-sensitive idiopathic hypertension.
Hypertension
11:
312-319,
1988[Abstract/Free Full Text].
10.
Grenader, A.,
and
D. P. Healy.
A68930 is a potent, full agonist at dopamine 1 (D1) receptors in renal epithelial LLC-PK1 cells.
Br. J. Pharmacol.
106:
229-230,
1992[Medline].
11.
Grenader, A.,
and
D. P. Healy.
Locally formed dopamine stimulates cAMP accumulation in LLC-PK1 cells via a DA1 dopamine receptor.
Am. J. Physiol.
260 (Renal Fluid Electrolyte Physiol. 29):
F906-F912,
1991[Abstract/Free Full Text].
12.
Grossman, E.,
D. S. Goldstein,
A. Hoffman,
I. R. Wacks,
and
M. Epstein.
Effects of water immersion on sympathoadrenal and dopa-dopamine systems in humans.
Am. J. Physiol.
262 (Regulatory Integrative Comp. Physiol. 31):
R993-R999,
1992[Abstract/Free Full Text].
13.
Hagege, J.,
and
G. Richet.
Proximal tubule dopamine histofluorescence in renal slices incubated with L-dopa.
Kidney Int.
27:
3-8,
1985[Medline].
14.
Hayashi, M.,
Y. Yamaji,
W. Kitajima,
and
T. Saruta.
Effects of high salt intake on dopamine production in rat kidney.
Am. J. Physiol.
260 (Endocrinol. Metab. 23):
E675-E679,
1991[Abstract/Free Full Text].
15.
Heikkila, R. E.,
and
L. Manzino.
Behavioral properties of GBR 12909, GBR 13069 and GBR 13098: specific inhibitors of dopamine uptake.
Eur. J. Pharmacol.
103:
241-248,
1984[Medline].
16.
Hull, R. N.,
W. R. Cherry,
and
G. W. Weaver.
The origin and characteristics of a pig kidney cell strain, LLC-PK1.
In Vitro
12:
670-677,
1976[Medline].
17.
Iimura, O.,
and
K. Shimamoto.
Suppressed dopaminergic activity and water-sodium handling in the kidneys at the prehypertensive stage of essential hypertension.
J. Auton. Pharmacol.
10:
s73-s77,
1990.
18.
Jose, P. A.,
J. R. Raymond,
M. D. Bates,
A. Aperia,
R. A. Felder,
and
R. M. Carey.
The renal dopamine receptors.
J. Am. Soc. Nephrol.
2:
1265-1278,
1992[Abstract].
19.
Lee, M. R.
Dopamine and the kidney: ten years on.
Clin. Sci. (Lond.)
84:
357-375,
1993[Medline].
20.
Motulsky, H. J.,
P. Spannard,
and
R. Neubig.
GraphPad Prism (version 1.0). San Diego, CA: GraphPad Prism Software, 1994.
21.
Neame, K. D.,
and
T. G. Richards.
Elementary Kinetics of Membrane Carrier Transport. Oxford, UK: Blackwell Scientific, 1972.
22.
Seri, I.,
B. C. Kone,
S. R. Gullans,
A. Aperia,
B. M. Brenner,
and
B. J. Ballermann.
Influence of Na+ intake on dopamine-induced inhibition of renal cortical Na+-K+-ATPase.
Am. J. Physiol.
258 (Renal Fluid Electrolyte Physiol. 27):
F52-F60,
1990[Abstract/Free Full Text].
23.
Seri, I.,
B. C. Kone,
S. R. Gullans,
A. Aperia,
B. M. Brenner,
and
B. J. Ballermann.
Locally formed dopamine inhibits Na+-K+-ATPase activity in rat renal cortical tubule cells.
Am. J. Physiol.
255 (Renal Fluid Electrolyte Physiol. 24):
F666-F673,
1988[Abstract/Free Full Text].
24.
Shirota, K.,
and
H. Fujisawa.
Purification and characterization of aromatic L-amino acid decarboxylase from rat kidney and monoclonal antibody to the enzyme.
J. Neurochem.
51:
426-434,
1988[Medline].
25.
Siragy, H. M.,
R. A. Felder,
N. L. Howell,
R. L. Chevalier,
M. J. Peach,
and
R. M. Carey.
Evidence that intrarenal dopamine acts as a paracrine substance at the renal tubule.
Am. J. Physiol.
257 (Renal Fluid Electrolyte Physiol. 26):
F469-F477,
1989[Abstract/Free Full Text].
26.
Soares-da-Silva, P.
Actin cytoskeleton, tubular sodium and the renal synthesis of dopamine.
Biochem. Pharmacol.
44:
1883-1886,
1992[Medline].
27.
Soares-da-Silva, P.
Enhanced protein kinase C mediated inhibition of renal dopamine synthesis during high sodium intake.
Biochem. Pharmacol.
45:
1791-1800,
1993[Medline].
28.
Soares-da-Silva, P.
Nature and kinetic characteristics of L-DOPA uptake in rat renal proximal tubules.
Amino Acids (Vienna)
8:
265-270,
1995.
29.
Soares-da-Silva, P.
Source and handling of renal dopamine: its physiological importance.
News Physiol. Sci.
9:
128-134,
1994.[Abstract/Free Full Text]
30.
Soares-da-Silva, P.,
and
M. H. Fernandes.
Effect of alpha-human atrial natriuretic peptide on the synthesis of dopamine in the rat kidney.
Br. J. Pharmacol.
105:
869-874,
1992[Medline].
31.
Soares-da-Silva, P.,
and
M. H. Fernandes.
Inhibitory effects of guanosine 3':5'-cyclic monophosphate on the synthesis of dopamine in the rat kidney.
Br. J. Pharmacol.
103:
1923-1927,
1991[Medline].
32.
Soares-da-Silva, P., and M. H. Fernandes.
Regulation of dopamine synthesis in the rat kidney.
J. Auton. Pharmacol. 10, Suppl. 1: S25-S30, 1990.
33.
Soares-da-Silva, P.,
and
M. H. Fernandes.
Sodium-dependence and ouabain-sensitivity of the synthesis of dopamine in renal tissues of the rat.
Br. J. Pharmacol.
105:
811-816,
1992[Medline].
34.
Soares-da-Silva, P.,
M. H. Fernandes,
and
M. Pestana.
Studies on the role of sodium on the synthesis of dopamine in the rat kidney.
J. Pharmacol. Exp. Ther.
264:
406-414,
1993[Abstract/Free Full Text].
35.
Soares-da-Silva, P.,
M. H. Fernandes,
and
P. C. Pinto-do-Ó.
Cell inward transport of L-DOPA and 3-O-methyl-L-DOPA in rat renal tubules.
Br. J. Pharmacol.
112:
611-615,
1994[Medline].
36.
Soares-da-Silva, P.,
M. Pestana,
and
M. H. Fernandes.
Involvement of tubular sodium in the formation of dopamine in the human renal cortex.
J. Am. Soc. Nephrol.
3:
1591-1599,
1993[Abstract].
37.
Soares-da-Silva, P.,
M. Pestana,
M. A. Vieira-Coelho,
M. H. Fernandes,
and
A. Albino-Teixeira.
Assessment of renal dopaminergic system activity in the nitric oxide-deprived hypertensive rat model.
Br. J. Pharmacol.
114:
1403-1413,
1995[Medline].
AJP Renal Physiol 274(2):F243-F251
0363-6127/98 $5.00
Copyright © 1998 the American Physiological Society